Text Size

Perfusion CT Registry

This study is currently recruiting participants.
Verified September 2012 by Asan Medical Center
Sponsor:
Information provided by (Responsible Party):
Young-Hak Kim, MD, PhD, Asan Medical Center
ClinicalTrials.gov Identifier:
NCT01696006
First received: September 26, 2012
Last updated: NA
Last verified: September 2012
History: No changes posted
  Purpose

The purpose of this study is to determine whether coronary perfusion computed tomography is effective in the treatment of coronary artery disease.


Condition
Coronary Artery Disease

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Asan Medical Center:

Primary Outcome Measures:
  • Accuracy of coronary perfusion computed tomography [ Time Frame: 5year ] [ Designated as safety issue: No ]
    Positive predictive value Negative predictive value Sensitivity Specificity


Secondary Outcome Measures:
  • Relationship between coronary perfusion computed tomography and fraction flow reserve [ Time Frame: 5year ] [ Designated as safety issue: No ]
  • Relationship between coronary perfusion computed tomography and SPECT(nuclear imaging) [ Time Frame: 5year ] [ Designated as safety issue: No ]
  • occurrence of the event after coronary perfusion computed tomography [ Time Frame: 5year ] [ Designated as safety issue: Yes ]
    Death Myocardial infarction coronary angiography Revascularization


Estimated Enrollment: 500
Study Start Date: September 2012
Estimated Study Completion Date: December 2019
Estimated Primary Completion Date: September 2018 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   20 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

General hospital

Criteria

Inclusion Criteria:

  • age greater than or equal to 20
  • Patient who has a coronary perfusion computed tomography

Exclusion Criteria:

  • Unwillingness or inability to give informed consent
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01696006

Contacts
Contact: Young-Hak Kim, MD,PhD 82-2-3010-3955 mdyhkim@amc.seoul.kr

Locations
Korea, Republic of
Asan Medical Center Recruiting
Seoul, Songpa-Gu, Korea, Republic of
Contact: Young-Hak Kim, MD, PhD     82-2-3010-3955     mdyhkim@amc.seoul.kr    
Principal Investigator: Young-Hak Kim, MD,PhD            
Sponsors and Collaborators
Young-Hak Kim, MD, PhD
  More Information

No publications provided

Responsible Party: Young-Hak Kim, MD, PhD, Asan Medical Center
ClinicalTrials.gov Identifier: NCT01696006     History of Changes
Other Study ID Numbers: AMCCV 2012-04
Study First Received: September 26, 2012
Last Updated: September 26, 2012
Health Authority: Korea: Institutional Review Board

Keywords provided by Asan Medical Center:
perfusion computed tomography
coronary artery disease

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Diseases
 Cardiovascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on May 23, 2013